Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Upexi Inc (NASDAQ: UPXI) closed the day trading at $6.66 up 18.51% from the previous closing price of $5.62. In other words, the price has increased by $18.51 from its previous closing price. On the day, 10.23 million shares were traded. UPXI stock price reached its highest trading level at $6.73 during the session, while it also had its lowest trading level at $5.5.
Ratios:
For a better understanding of UPXI, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.24 and its Current Ratio is at 0.37. In the meantime, Its Debt-to-Equity ratio is 5.02 whereas as Long-Term Debt/Eq ratio is at 1.31.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Alliance Global Partners on August 04, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
On June 16, 2025, Cantor Fitzgerald Upgraded its rating to Overweight which previously was Neutral but kept the price unchanged to $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 11 ’25 when Salkind Gene bought 20,243 shares for $4.94 per share. The transaction valued at 100,000 led to the insider holds 385,370 shares of the business.
Dugan Lawrence bought 11,000 shares of UPXI for $62,600 on Jul 16 ’25. The Director now owns 112,389 shares after completing the transaction at $5.69 per share. On Jul 22 ’25, another insider, Dugan Lawrence, who serves as the Director of the company, bought 4,000 shares for $7.50 each. As a result, the insider paid 30,000 and bolstered with 116,389 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UPXI now has a Market Capitalization of 358258048 and an Enterprise Value of 257238592. Its current Enterprise Value per Revenue stands at 15.532 whereas that against EBITDA is -15.16.
Stock Price History:
The Beta on a monthly basis for UPXI is -0.46, which has changed by 0.6403941 over the last 52 weeks, in comparison to a change of 0.18157876 over the same period for the S&P500. Over the past 52 weeks, UPXI has reached a high of $22.57, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -3.72%, while the 200-Day Moving Average is calculated to be 16.18%.
Shares Statistics:
Over the past 3-months, UPXI traded about 5.83M shares per day on average, while over the past 10 days, UPXI traded about 7711040 shares per day. A total of 53.79M shares are outstanding, with a floating share count of 42.17M. Insiders hold about 21.60% of the company’s shares, while institutions hold 36.22% stake in the company. Shares short for UPXI as of 1753920000 were 6636098 with a Short Ratio of 1.14, compared to 1751241600 on 1185309. Therefore, it implies a Short% of Shares Outstanding of 6636098 and a Short% of Float of 12.4.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.01 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.81 and -$0.92 for the fiscal current year, implying an average EPS of -$0.87. EPS for the following year is -$0.03, with 2.0 analysts recommending between $0.03 and -$0.09.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $7.33M. There is a high estimate of $9.16M for the next quarter, whereas the lowest estimate is $5.5M.
Based on 2 analysts’ estimates, the company’s revenue will be $31.45M in the next fiscal year. The high estimate is $38.09M and the low estimate is $24.8M.
